HHS SBIR PHS 201301

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should use the agency link listed below which will take you directly to the appropriate agency server where you can read the official version of this solicitation and download the appropriate forms and rules.

The official link for this solicitation is: http://grants.nih.gov/grants/funding/SBIRContract/PHS2013-1.pdf

Available Funding Topics

  • 001: Visualizing Knowledge about Human Health and the Pathways of Translation
  • 002: Biomarker Study for Creatine Transporter Defect Disorders
  • 002: Improved Methods for Collection, Preservation, and Transportation of Biological Specimens
  • 003: Automated Instrument to Clean Microtiter Plates
  • 003: Diagnostic Needs for Neglected Tropical Diseases (NTD) Programs
  • 003: Development of Nanoparticle Dengue Diagnostic Tests
  • 004: Assay Development for High-Throughput Screening of Chemicals of Toxicological Concern
  • 004: Rapid Screening Tests to Prevent Congenital Infections and Ensure Blood Safety
  • 004: Development of Tests in a Standardized Kit Format for Diagnosis of Arboviral Infections in Resource-Limited, Primary Health Care Setting
  • 005: Development of Diagnostic Tests for Strongyloidiasis and Schistosomiasis
  • 005: Reducing Antimicrobial Resistance through Improved use of Laboratory Testing Information in Healthcare Facilities
  • 016: Improving Data, Improving Care, Making it Count
  • 017: Smartphone Application for Global Birth Defects Surveillance
  • 021: Aerosolized Delivery of Anti-Tubercular Drugs
  • 022: Development of Long-Acting Formulations of HIV Anti-Retrovirals
  • 023: Improved Formulations for Approved First and Second line anti-Tuberculosis (TB) Drugs
  • 023: Neural Interfaces: Improving Functional Outcomes
  • 024: Integrated Multiplex Medical Diagnostics Platforms for Infectious Diseases
  • 025: Development of an Inactivated Rotavirus Vaccine for Use in Global Immunization
  • 026: Thermostable Dry Measles Vaccine Formulation for Sublingual Administration
  • 033: A Mobile Phone Application (“App”) for Advancing Teen Pregnancy Prevention
  • 034: Development of Biomedical Devices to Elicit Durable Protective Immunity against HIV
  • 035: Development of a Portable Multiplex Assay for Determination of Recent HIV-1 Infection
  • 036: Testing the Efficacy of Combination HIV Prevention Strategies in Nonhuman Primates
  • 072: New Methods to Detect and Assess Myocardial Fibrosis
  • 073: Evaluating Obstructive Sleep Apnea Dental Device Treatment Compliance
  • 074: Improving Safety and Efficacy of Red Blood Cells for Transfusion
  • 075: Dedicated Pediatric Cardiac MRI Receive Coils
  • 076: MRI Myocardial Biopsy Forceps
  • 077: Passive MRI Guidewire
  • 078: Transthoracic Cardiac Access Ports and Closure Devices
  • 079: Bioabsorbable Stents for Pediatric Pulmonary Artery Stenosis and Aortic Coarctation
  • 080: Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging
  • 147: A Mobile Application to Help Patients Take their Pill Medications as Prescribed: Improving Medication Adherence
  • 148: Products for at-home Deactivation of Psychoactive Prescription Medicines
  • 149: Development of Predictive in vivo Screening Systems for Phenotypic Drug Discovery for Smoking Cessation
  • 150: Video Game Targeting Relapse Prevention in Youth with Substance Use Disorders
  • 313: RNAi Cancer Therapeutics using Nanotechnology
  • 314: Development of Human Tissue Culture Systems that Mimic the Tumor Microenvironment
  • 315: Development of Companion Diagnostics: Enabling Precision Medicine in Cancer Therapy
  • 316: Development of CTC Isolation Technologies Enabling Downstream Single Cell Molecular Analysis
  • 317: Wound Healing Preparations Incorporating Nitric Oxide-Releasing Materials (NIH Technology Transfer)
  • 318: Test to Predict Effectiveness of Docetaxel Treatment for Prostate Cancer (NIH Technology Transfer)
  • 319: Technology to Generate Anti-Peptide Capture Reagents for Affinity-Enriched Proteomic Studies
  • 320: High Quality Cancer-Related Standards for Metabolomics Research
  • 321: Chemically Defined Glycan Libraries for Reference Standards and Glycomics Research (Joint NCI-NIGMS Program)
  • 322: Real-Time Integration of Sensor and Self-Report Data for Clinical and Research Applications
  • 323: Development of Radiation Modulators for Use During Radiotherapy
  • 324: Novel Imaging Agents to Expand the Clinical Toolkit for Cancer Diagnosis, Staging, and Treatment
  • 325: Innovative Radiation Sources for Advanced Radiotherapy Equipment

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government